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Abstract 
Background: Suboptimal health status (SHS) is a physical state between health and disease, characterized by the 
perception of health complaints, general weakness, chronic fatigue and low energy levels. SHS is proposed by the 
ancient concept of traditional Chinese medicine (TCM) from the perspective of preservative, predictive and personal-
ized (precision) medicine. We previously created the suboptimal health status questionnaire 25 (SHSQ-25), a novel 
instrument to measure SHS, validated in various populations. SHSQ-25 thus affords a window of opportunity for early 
detection and intervention, contributing to the reduction of chronic disease burdens.
Methods/design: To investigate the causative effect of SHS in non-communicable chronic diseases (NCD), we initi-
ated the China suboptimal health cohort study (COACS), a longitudinal study starting from 2013. Phase I of the study 
involved a cross-sectional survey aimed at identifying the risk/protective factors associated with SHS; and Phase II: a 
longitudinal yearly follow-up study investigating how SHS contributes to the incidence and pattern of NCD.
Results: (1) Cross-sectional survey: in total, 4313 participants (53.8 % women) aged from 18 to 65 years were 
included in the cohort. The prevalence of SHS was 9.0 % using SHS score of 35 as threshold. Women showed a signifi-
cantly higher prevalence of SHS (10.6 % in the female vs. 7.2 % in the male, P < 0.001). Risk factors for chronic diseases 
such as socioeconomic status, marital status, highest education completed, physical activity, salt intake, blood pres-
sure and triglycerides differed significantly between subjects of SHS (SHS score ≥35) and those of ideal health (SHS 
score <35). (2) Follow up: the primary and secondary outcomes will be monitored from 2015 to 2024.
Conclusions: The sex-specific difference in prevalence of SHS might partly explain the gender difference of inci-
dence of certain chronic diseases. The COACS will enable a thorough characterization of SHS and establish a cohort 
that will be used for longitudinal analyses of the interaction between the genetic, lifestyle and environmental factors 
that contribute to the onset and etiology of targeted chronic diseases. The study together with the designed prospec-
tive cohort provides a chance to characterize and evaluate the effect of SHS systemically, and it thus generates an 
unprecedented opportunity for the early detection and prevention of chronic disease.
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Background
Major chronic diseases such as hypertension, heart dis-
ease, stroke, cancer, chronic obstructive pulmonary dis-
ease and diabetes caused an estimated 35 million deaths 
in 2005, 80  % of which occurred in low and middle 
income countries such as China [1–3]. Mortality rates 
of non-communicable chronic diseases (NCD) have 
been declining in most western countries, but NCD are 
increasing in China as a result of adverse changes such 
as lifestyle, environmental pollution, diet and tobacco 
use [4–6]. In the past 30  years, China has experienced 
dramatic transformations in social and economic con-
ditions, and these changes will continue to increase the 
incidences of major chronic diseases [7]. From 1990 to 
2010, the proportion of people living in urban cities in 
China increased from 26 to 50 % [8, 9]. It is expected that 
urbanization in China will reach 60  % by 2020, accord-
ing to the official forecast [10]. The rapid environmen-
tal changes accompanied with urbanization lead to the 
increasing prevalence of the major risk factors for NCD, 
including work stress, physical inactivity, unhealthy diet, 
and tobacco use; therefore, as a result, the prevalence of 
NCD will continue to increase [7].
China is a country with 5000 years of civilization, and 
traditional Chinese medicine (TCM) is one of the pres-
tigious medical heritages in the world, with over 2 mil-
lennia of clinical practices [8, 9]. Unfortunately, some of 
the TCM conceptions have not been recognized interna-
tionally due to the lack of systemic evidenced supports 
[10]. Suboptimal health status (SHS) is such an example. 
SHS is a physical state between health and disease, char-
acterized by the perception of health complaints, general 
weakness, chronic fatigue and low energy levels [11]. We 
have also developed a tool to measure SHS. Our subop-
timal health status questionnaire-25 (SHSQ-25) assesses 
five components of health [11, 12]. To date, the SHSQ-25 
as a self-reported survey tool has been validated in vari-
ous populations, including European ethic group [12–
16], and currently SHSQ-25 has also being applied to a 
real life community-based health survey in Ghana, west-
ern Africa. SHS thus has been recognized internation-
ally and it works a novel tool for the early detection of 
chronic disease [12–16]. We also found SHS to be associ-
ated with cardiovascular risk factors and may contribute 
to the development of cardiovascular disease. SHS has 
also been reported to be associated with chronic psycho-
social stress [14–16] and poor lifestyle factors [17, 18].
Studies to improve early detection and intervention of 
NCD will become increasingly important, and the avail-
ability of reliable biomarkers for these diseases will be 
essential. Specific biomarkers, such as plasma glycome or 
serum peptidome, are believed to represent an ‘interme-
diate phenotype’ in the etiology of adult-onset diseases 
[19, 20]. Therefore, these profiles might hold the key in 
understanding the underlying biological mechanisms that 
create SHS. The SHSQ-25 promises to be a window of 
opportunity for early detection and intervention to reduce 
chronic disease burden [15]. The inclusion of the “objec-
tive” biomarkers and the subjective “SHS” assessment into 
population studies is therefore believed to be timely in 
improving chronic disease control and in strengthening 
opportunities for chronic disease prevention.
Although case-control studies may be sufficient for 
the investigation of potential impacts of genetic or envi-
ronmental factors, large community-based prospective 
cohort studies are essential for the unbiased assessment of 
the relevance of both environmental and genetic factors, 
and their interactions. There have already been several 
prospective studies of major chronic diseases in China 
[21–25]. However, there are limitations, such as small 
sample size [21–23], lack of biological samples to meas-
ure biomarkers [24, 25], or limited definite information 
on environmental exposures and outcome of health status 
measures [21, 24, 25]. Moreover, the association between 
SHS and major chronic diseases in China is still poorly 
understood, and there is still substantial uncertainty about 
the present and future relevance to population morbidity 
and mortality of many common risk factors [25].
The China suboptimal health cohort study (COACS) 
uses a multidisciplinary approach to understand the 
impact of SHS on chronic diseases. The strategy is to 
study a moderately large cohort intensively, collecting 
data from a wide range of measures including physical 
function, cognition, medical history and SHS, as well as 
biological samples annually. This will assist in decipher-
ing the important relationships between disease process 
and risk factors within individuals. The study aims to 
establish a cohort for investigators to comprehensively 
understand the potential significance of SHS combined 
with profiling of dynamic biomarkers for NCD patho-
genesis. The COACS provides a platform from which 
early intervention strategies can be implemented and 
evaluated.
The COACS is designed based on the following hypoth-
esis: the combination of genetic background, proofing 
of dynamic biomarkers and environmental exposures, 
in parallel with the application of the subjective health 
metrics (SHSQ-25) will contribute to risk stratification 
of chronic diseases, and serve as prognostic indicators 




The COACS Study is a community-based, prospec-
tive study, to investigate how suboptimal health status 
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contributes to the incidence of NCD in Chinese adults. 
The study has two phases, a cross-sectional survey, fol-
lowed by a longitudinal study. The participants were 
recruited from Caofeidian district, Tangshan city, in 
northern China. Caofeidian district is located in the 
south of the Tangshan city and near the Bohai sea, with 
an area of 1944 km2 and a population of 268.7 thousand 
(According to 2012 China census), from September 2013 
to June 2014. Tangshan is a large, modern industrial city 
located in the central section of the circum-Bohai region, 
where it adjoins two mega cities: Beijing and Tianjin 
(Table 1).
In phase I, all participants underwent extensive clinical, 
laboratory and environmental exposure measurements 
aimed at identifying clinical, biological, environmen-
tal and genetic factors associated with SHS. In the sec-
ond phase, a long-term yearly clinical follow-up will be 
performed until 2024, with the purpose of better under-
standing how SHS, environmental and genetic risk fac-
tors contribute to the development of major chronic 
diseases.
We estimated the sample size based on the incidence 
of cerebrovascular and cardiovascular morbidity in the 
peripheral arterial disease study (PERART/ARTPER) 
[26]. The incidence of cerebrovascular and cardiovascular 
morbidity was reported to be 1124 and 2117 per 100,000 
person-year respectively in a Mediterranean low car-
diovascular risk population [26]. Based on the combined 
incidence in ARTPER cohort (3241 per 100,000 popu-
lation), α = 0.05, β = 0.10, proposed odds ratio (OR) of 
1.50 (high SHS score group vs. low SHS score group), and 
the prevalence ratio of high SHS score group vs. low SHS 
score group of 1:5, the sample sizes of high and low SHS 
score groups were estimated to be 278 and 1390 respec-
tively (PASS 11) [27]. Considering attrition rate of 10 %, 
a sample size of 306 for high SHS group and 1530 for 
low SHS group met the minimum required sample size. 
In actuality, 9078 participants were recruited, which is 5 
times that of the required sample size.
Inclusion criteria
All adults (from 18 to 65  years old) participating in the 
baseline investigation, and those who were also willing 
to be involved in future follow-up investigations were 
included into the study.
Exclusion criteria
Participants currently suffering from diabetes (self-reported 
diabetes or FPG ≥ 7.0 mmol/L at the investigation), hyper-
tension (self-reported hypertension, or SBP ≥ 140 mmHg, 
or DBP  ≥  90  mmHg at the investigation), hyperlipemia 
(self-reported), cardiovascular or cerebrovascular condi-
tions (including self-reported atrial fibrillation, atrial flut-
ter, heart-failure, myocardial infarction, transient ischemic 
attack, and stroke), any type of cancer (self-reported), and 
gout (self-reported) were excluded.
Phase I cross‑sectional survey
Data collection by questionnaires
All participants were asked to complete a set of combined 
self-administered questionnaires (including SHSQ-25) 
with the assistance of a well-trained research assistant. 
The questionnaires collected the following information:
SHS measurements SHS questionnaire (SHSQ-25) was 
used to measure SHS [12–16]. The SHSQ-25 contains 25 
items under the 5 domains of fatigue, the cardiovascu-
lar system, the digestive tract, the immune system, and 
mental status. Each subject was asked to rate a specific 
statement on a 5-point scale. The raw scores of 1–5 on 
the questionnaire were recorded as 0–4. SHS scores 
were calculated for each respondent by summing the 
ratings for the 25 items. A high score (≥35) represents 
a high level of SHS (poor health), with a score of ≥35 
regarded as SHS, and the remains are ideal health [28]. 
The Cronbach’s α coefficient of the SHSQ-25 in previous 
investigation was 0.91, indicating good individual inter-
nal consistency [12].
Demographics Age (date of birth), sex, marital status, 
nationality, education level, and household income.
Lifestyle, physical activity and  environmental fac-
tors Information on drinking history, active smoking or 
passive smoking at home or work was recorded. The cur-
rent information on tobacco, alcohol and tea consump-
tion, dietary intakes of meat, fruit, vegetable, dairy, cereals 
and salt were also collected.
Physical activity and sedentary behavior were assessed 
using the short form of the International physical activity 
Table 1 Testing program in  the China suboptimal health 
cohort study
Test Components
Specimen collection Fasting blood sample
Anthropometry Height, weight, ankle-branchial index, waist and 
hip circumference
Participant break Refreshment break with food provided
Cardiovascular 12 lead ECG, vascular profiling (blood pressures, 
pulse wave velocity), transcranial doppler, 
carotid artery sonography
Respiratory Obstructive spirometry
Skeleton Bone density examination
Gynecology (female) Gynecologic examination, pap smear, pelvic 
ultrasound
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questionnaire (IPAQ) [29]. We collected the average 
sleeping hours over a 24-h period.
Medical history and physical symptoms Current use of 
medication and supplements were collected, as well as 
medical history including age at diagnosis of the following 
diseases;
Cardiovascular or cerebrovascular conditions: atrial 
fibrillation, heart-failure, myocardial infarction, transient 
ischemic attack, and stroke.
Endocrine conditions: diabetes and gout.
Neurological conditions: Alzheimer’s disease, vascular 
dementia (multi-infarct dementia), Parkinson’s disease, 
attention deficit (hyperactivity) disorder, anxiety disorder.
Sleep disorders: narcolepsy and obstructive sleep 
apnoea.
Other medical conditions: cancer, and cataclasis.
Sleep symptoms such as day-time somnolence, snoring 
frequency, witnessed apnoeas, frequency of unrefreshed 
sleep and waking tired or falling asleep while driving 
were assessed using the Epworth sleepiness scale [30] and 
the Berlin questionnaire [31].
Mental health was also assessed using the depression, 
anxiety and stress scale (DASS21) [32] and depressive 
severity measured using the patient health question-
naire-9 (PHQ-9) [33]. Information on current treatment 
for depression including medication, exercise or psycho-
logical counseling was also collected.
Physical examination
Blood sample collection and  biochemistry tests Blood 
samples were collected from the antecubital vein of all 
participants in the morning under fasting conditions. 
They were stored in vacuum tubes containing EDTA 
(ethylene diamine tetraacetic acid) and coagulation 
tubes. A range of haematological and biochemistry tests 
(Table  2) were conducted on fresh samples at the cen-
tral laboratory of the Staff Hospital of Jidong oil-field of 
Chinese National Petroleum. Fasting blood glucose was 
measured with the hexokinase/glucose-6-phosphate 
dehydrogenase method. Cholesterol and triglyceride 
concentrations were determined by enzymatic methods 
(Mind Bioengineering Co. Ltd, Shanghai, China). Blood 
samples were also measured using an auto-analyzer 
(Hitachi 747; Hitachi, Tokyo, Japan) at the central labo-
ratory of the Staff Hospital of Jidong oil-field of Chinese 
National Petroleum. For all participants, serum creati-
nine, cholesterol, high-density lipoproteins (HDL-C), 
low-density lipoproteins (LDL-C), triglycerides and glu-
cose levels were assessed. In subgroup analysis studies, 
various biomarkers of blood cells, serum and plasma 
were measured: C-reactive protein, homocysteine, 
estrogens, androgens, vitamin D, lipoprotein-associated 
phospholipase A2 (Lp-PLA2), insulin, and glycosylated 
hemoglobin HbA1c.
Blood samples were processed and separated onsite 
for biospecimen banking (−80 °C). DNA and RNA were 
extracted and stored in the laboratory of Beijing Key Lab-
oratory of Clinical Epidemiology, Beijing, China.
Table 2 Haematology, biochemistry and  biological speci‑
men banking in the COACS
Analysate
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Cardiovascular and  cerebrovascular A resting 12-lead 
electrocardiogram (ECG) and rhythm strip was recorded 
digitally using a Cardio Perfect PC-Based resting ECG 
system (Welch Allyn). The ankle brachial index (ABI) 
measurement was used to determine peripheral arterial 
disease (PAD) using a standard method [34]. Transcranial 
Doppler was performed by two experienced neurologists 
with portable examination devices (EME Companion, 
Nicolet, Madison, WI, USA) to determine intracranial 
arterial stenosis (ICAS), which was diagnosed according 
to the peak flow velocity based on published criteria [35]. 
Bilateral carotid duplex ultrasound was used to evaluate 
extracranial carotid stenosis (ECAS), with carotid steno-
sis (≥50  %) based on recommendations from the Soci-
ety of Radiologists in Ultrasound Consensus Conference 
[36].
Respiratory Forced expired volume in one second 
(FEV1) and forced vital capacity (FVC), before and 15 min 
after salbutamol (200 mcg) delivered via a metered-dose 
inhaler and spacer, were measured using an Asyone™ 
spirometer and compared with predicted values [37].
Cognition Memory and attention were assessed using 
the Cognitive Drug Research (CDR) computerized assess-
ment system (United BioSource Corporation, UK), which 
is widely used in clinical and longitudinal studies, includ-
ing the dementias, and had been shown to be sensitive to 
subtle cognitive changes [38].
Anthropometry and body composition Standing height, 
waist and hip girth, and weight were measured with the 
participant lightly-clothed and shoeless using standard 
anthropometric techniques. Body mass index (BMI) was 
calculated as well as waist to hip ratio (WHR). Blood 
pressure was determined to the nearest 2 mmHg using a 
mercury sphygmomanometer with a cuff of appropriate 
size. Two readings of systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) were taken at a five-minute 
interval, and the mean of the two readings was taken as the 
BP value. Arterial hypertension was defined based on the 
following information alone or in combination: (1) with a 
history of arterial hypertension; (2) using antihypertensive 
medication; or (3) a systolic blood pressure >140 mmHg, 
or a diastolic blood pressure of >90 mmHg.
Dual energy X-ray absorptiometry (DEXA) scans (AP 
spine and dual femur) were undertaken to assess bone 
mineral density (BMD) using a GE Lunar Prodigy Pro 
densitometer and enCORE Version 13 (GE Health) soft-
ware. Bone mineral density was measured in grams per 
centimeter squared (g/cm2) and young adult T-scores 
and age-matched z-scores were derived using the com-
bined Geelong/Lunar reference database (GE Health).
Phase II Scheduled follow‑up study
Follow‑up
The study participants will be followed up via face-
to-face interviews once every year in a routine medi-
cal examination up to December 31, 2024, or up to the 
occurrence of a final event as defined in the study, or 
occurrence of death. In every interview, information on 
SHS, demographics, lifestyle, activity and environment, 
medical history and physical symptoms, blood samples, 
anthropometry and body composition, cardiovascular 
and cerebrovascular, and cognition will be collected. Data 
on clinical outcomes will be collected through a standard 
operational procedure follow-up system. The follow-up 
system involves linkage of the study base to files from 
general practitioners in the study area and subsequent 
collection of information from letters of medical special-
ists and discharge reports in case of hospitalization. With 
respect to the vital status of participants, information 
will also be obtained regularly from the municipal health 
authority in Tangshan city.
A diagnosis of major disease is confirmed only after 
review of the medical records by an End Points Com-
mittee of physicians that includes experts such as car-
diologists, neurologists, and oncologists. An End Points 
Committee of physicians including membership, role and 
responsibilities has been approved by the Project Execu-
tive Committee.
Primary outcomes
Cardiovascular events Clinical cardiovascular outcomes 
will be coded by study physicians and medical experts in 
the field according to the International classification of 
diseases, 10th edition (ICD-10). Incident coronary heart 
disease is defined as the occurrence of a fatal or nonfa-
tal myocardial infarction (I21), other forms of acute (I24) 
or chronic ischemic (I25) heart disease, sudden (cardiac) 
death (I46 and R96), death caused by ventricular fibrilla-
tion (I49), or death resulting from congestive heart failure 
(I50) during follow-up [39]. Other outcomes include heart 
failure [40] and atrial fibrillation [41].
Cerebrovascular events The primary outcome will be 
the first occurrence of stroke, either the first nonfatal 
stroke event, or stroke death without a preceding nonfatal 
event. A nonfatal stroke is defined as a focal neurologi-
cal deficit of sudden onset and vascular mechanism that 
lasts for >24 h. Cases of fatal stroke will be documented 
by evidence of a cerebrovascular mechanism obtained 
from all available sources, including death certificates, 
medical insurance and hospital records. Stroke will be 
classified according to the criteria as ischemic stroke, and 
hemorrhagic stroke (ICD-10 codes: G45, I63, I61, I60). 
The diagnosis will be confirmed by the evidences of brain 
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X-ray computed tomography (CT) or magnetic resonance 
imaging (MRI) [42], which are classified into brain infarc-
tion, intracerebral hemorrhage, and subarachnoid hem-
orrhage. Lacunar infarction and stroke diagnosed just by 
imaging or as the second diagnosis will be excluded.
The secondary outcomes
The secondary outcomes will include: type 2 diabetes 
(T2D), chronic obstructive pulmonary disease (COPD), 
and other chronic diseases.
Type 2 diabetes (ICD-10: E11) is defined as the pres-
ence of any of the following criteria: (1) fasting plasma 
glucose value of ≥126 mg/dl (7.0 mmol/L) on two occa-
sions or symptoms of diabetes and a casual plasma glu-
cose value of  ≥200  mg/dl (11.1  mmol/L) or both, (2) 
current use of insulin or oral hypoglycemic agents, or (3) 
a positive response to the question:“Has a doctor ever 
told you that you have diabetes?”
COPD (ICD-10: J40-J47) is defined by a moderate-to-
severe obstructive spirometry (FEV1/FVC  <  0.70 and 
FEV1  <  80  % predicted), and/or as COPD diagnosed by 
a specialist in internal medicine (mainly respiratory 
physicians or internists with a subspecialty in respira-
tory medicine) based upon the combination of clinical 
history, physical examination and spirometry. Probable 
COPD is defined by a mild obstructive spirometry (FEV1/
FVC < 0.70 and FEV1 ≥ 80 % predicted) and/or as COPD 
diagnosed by a physician in another medical specialty 
(e.g., a general practitioner). Clinical outcomes will be 
collected during our continuous follow-up and include 
respiratory and non-respiratory death, hospitalizations 
due to exacerbations of COPD as well as moderate to 
severe COPD exacerbations treated with systemic corti-
costeroids and/or antibiotics.
Information about other chronic diseases, including 
hypertension, Alzheimer’s disease, Parkinson’s disease 
and other neurodegenerative diseases, cancer, chronic 
hepatitis, chronic osteoarticular diseases, osteoporosis, 
and chronic kidney disease, will also be collected.
Data capture and management
Hard copies of questionnaires were scanned and con-
verted to electronic portable document file (PDF) format 
and data was extracted and verified on-site using Cardiff 
TeleForm software (Verity Inc. Sunnyvale, CA). These 
data, along with automatic data capture capabilities from 
most of the devices being used are stored with the exist-
ing COACS collection which is managed by Beijing Key 
Laboratory of Clinical Epidemiology, Beijing, China.
Quality control (QC)
Each participant was assisted by a well-trained research 
assistant to fill in the questionnaires, and will be followed 
up by face-to-face interviews once every year in a routine 
medical examination. All research assistants, interview-
ers and physical examiners are trained in all items of the 
questionnaires, or all aspects of measurements (using 
standardized techniques). Trainings are conducted on-
site, and within the laboratories of each of the participat-
ing investigators under the supervision of experienced 
staff, until the required standard of testing and compe-
tency has been achieved.
During the course of the survey, regular central moni-
toring is also undertaken to assess the distribution of cer-
tain key variables, the time delay with blood processing 
and consistency of the data collected. On-site monitor-
ing visits are undertaken every 6-month by staff from 
Staff Hospital of Jidong oil-field of Chinese National 
Petroleum. In addition, QC monitoring regarding the 
follow-up has also been conducted by staff from a third 
party (Recovery Medical Technology Development 
Corporation).
Ethics statement
This study is performed according to the guidelines of 
the Declaration of Helsinki [43]. Approvals have been 
obtained from Ethical Committees of the Staff Hospital 
of Jidong oil-field of Chinese National Petroleum, Bei-
jing Tiantan Hospital, and Capital Medical University. 
These approvals will be renewed every 5  years. Written 




Questionnaire results and the results of physical and cog-
nitive testing were recorded to calculate and compare 
the level of risk factors in participants with SHS or ideal 
health. Normality distributions of continuous variables 
were tested by the Kolmogorov–Smirnov tests. Con-
tinuous variables were represented as Mean ± Standard 
Deviation, or Median (Percentile 25th–75th), while dis-
crete variables were represented as numbers (propor-
tion). The differences between groups were tested by t 
test or Wilcoxon rank sum test (skewed continuous vari-
ables or graded variables), or Chi square test (discrete 
variables). All reported P values were two-sided, and 
P < 0.05 was considered statistically significant.
Follow‑up longitudinal analysis
Changes from baseline to yearly follow-up in risk factors, 
sociodemographic factors, and the primary or secondary 
outcomes will be measured and relationships between 
them will be investigated using survival analysis, logistic 
regression, linear regression and cox regression models, 
or standard longitudinal data regression methods (such 
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as generalized mixed models and generalized estimation 
equation). These analyses will be focused on an under-
standing of the patterns and processes of chronic diseases 
and on the identification of factors that are contributing 
to the onset and incidence of chronic diseases.
Cross‑sectional survey results/baseline 
characteristics
The study recruited 9078 participants from Caofeidian 
district. However, 4765 were excluded from the study for 
one or more of the following reasons: they did not meet 
the inclusion criteria; did not complete the questionnaire; 
were unable to provide a blood sample, or had either a 
current, or a history of, chronic disease. Therefore, a total 
of 4313 participants were included in the COACS study, 
with 389 of SHS (SHS score ≥35) and 3924 of ideal health 
(SHS score <35). This would result in a power of 93.3 % 
in a planned 4-year follow-up or power of 90.90 %, given 
10 % of withdraw rate (see Fig. 1).
The descriptive characteristics of participants in 
COACS are summarized in Table 3. The mean age of the 
participants was 36.9 (±10.5) years with 53.8  % being 
women. The majority (59.1  %) had a household income 
between Chinese Yuan (CNY) ¥3000–5000 per month, 
and 87.6 % of them were married. About 70.9 % of par-
ticipants had completed college school or higher. Most 
of the participants never smoked (75.3  %), never drank 
(70.2  %), were Chinese Han (96.8  %), and had normal 
BMI (57.1  %). About 50.3  % of participants were active 
in physical activity, and 52.6 % had medium salt intakes. 
The prevalence of SHS in the investigated population was 
9.0  %, higher in women than in men (10.6 vs. 7.2  % in 
male and female, respectively).
The gender, socio-economic status, marital status, 
highest education completed, physical activity, salt 
intake, blood pressure and triglycerides differed signifi-
cantly between the SHS group and ideal health group 
(P  <  0.05), whereas the differences of age, ethnicity, 
smoking, drinking, BMI, fasting blood glucose and total 
cholesterol were of no statistical significance (Table 4).
Discussion
We define a subclinical, reversible stage of pre-chronic 
disease as the SHS [11, 12, 14]. It is a physical state 
between health and disease, characterized by the per-
ception of health complaints, general weakness, chronic 
fatigue and low energy levels within a period of 3 months 
[11, 12]. We have also developed a tool to measure SHS. 
Our SHSQ-25 assesses five components of health: fatigue, 
mental health, the digestive system, the cardiovascu-
lar system and the immune system [12–16]. However, 
whether and how the SHS contribute to the main chronic 
diseases (such as cardiovascular and cerebrovascular 
events, T2D, and COPD) remains unclear, and no exist-
ing cohort is available to investigate these contributions. 
To our knowledge, this is the first cohort study that 
includes measurements of SHS, which will enable the 
thorough characterization of SHS, and precisely estimate 
the incidence of chronic disease. This is based on the 
comprehensive assessments of both subjective and objec-
tive health statuses, together with lifestyle and environ-
mental factors.
At baseline of COACS, we found that gender, age, 
smoking, BMI, salt intake and blood pressure levels were 
significantly associated with SHS. Females had a higher 
SHS rate than males (10.6 vs. 7.2  %), indicating that 
women have a higher risk of developing NCD. The imbal-
ance of socio-economic, marital and education statuses 
between genders may contribute to this phenomenon, 
along with the natural physiological differences between 
males and females [16].
In addition, middle socio-economic status (¥3000–5000 
of household income) appears to be a protective factor 
for SHS, suggesting that middle income in a commu-
nity is associated with better health status. However, the 
existence of high physical activities in this group may be a 
confounding factor, thus providing a rational explanation 
to this outcome. We also found that marital status (wid-
owed, separated, divorced) is a risk factor for suboptimal 
health status. SHS has also been observed to be related 
to less physical activity and higher salt intakes (>6 g per 
day), which are known risk factors of cardiovascular and 
cerebrovascular diseases [14, 44]. The blood pressure and 
triglycerides were slightly lower in subjects of SHS than 
those of health (114.4  ±  11.1 vs. 117.1  ±  10.7  mmHg 
for SDP, 73.1 ±  8.3 vs. 74.6 ±  8.2  mmHg for DBP, and 
1.21 ± 0.74 vs. 1.33 ± 1.04 mmol/L for triglycerides). It 
is prudent to note that blood pressure and triglycerides 
levels that might be caused by the subjects of hyper-
tension or hyperlipidemia had been excluded from the 
recruitment.
Whilst SHS has been showed to be associated with car-
diovascular risk factors and chronic psychosocial stress 
[14, 16], little is known as to whether SHS contributes 
independently to the incidence of NCD. The SHSQ-25 
is a multidimensional, self-report symptom inventory 
including 5 health domains (fatigue, the cardiovascu-
lar system, the digestive tract, the immune system, and 
mental status), which match well with the physiological, 
psychological and social dimensions [12, 13] correspond-
ing to the greater understanding of WHO’s definition of 
health. SHS is associated with cardiovascular risk factors 
(higher SBP, DBP, FBG, total cholesterol, and lower HDL 
cholesterol) and contributes to the development of car-
diovascular diseases [14]. In addition, significantly higher 
levels of plasma cortisol and GRb/GRa mRNA ratio were 
Page 8 of 12Wang et al. J Transl Med  (2016) 14:291 
observed in the high SHS group than these in low SHS 
group [16]. The mechanism underlying SHS has yet to 
be ascertained, and the objective measurements for SHS 
are currently under investigation [16]. The COACS study 
was designed to examine the prevalence and associa-
tion of SHS in a general population, and to evaluate pro-
spectively the relationship between SHS and risk factors 
contributing to the incidence of NCD. This was achieved 
by using our novel SHSQ-25, along with objective meas-
urements of biomarkers. Preventable NCD accounts 
for an estimated 80  % of deaths and 70  % of disability-
adjusted life-years lost in China [7]. Therefore, a multi-
dimensional and multidisciplinary health promotion and 
disease management plan of NCD are urgently needed. 
The preventive and predictive approach, including com-
munity-based strategies and interventions for high risk 
factors at a population level, rely on a comprehensive 
understanding of relevant, current and integrated data on 
the prevalence, clustering of disease, known risk factors, 
and discovery of new risk factors [45]. The COACS will 
add novel knowledge across a broad range of areas by:
Stratifying the participants resident in a real community 
environment into SHS and ideal health
Using our SHSQ-25, the participants in the cohort 
are categorized into SHS and ideal health groups. To 
our knowledge, this is the first attempt in investigat-
ing whether, and to what extent, SHS contributes to the 
9,078 participants agreed to attend COACS in 2013/2014
8,596 subjects met the inclusion criterion 
(aged between 18 and 65 years)
1933 participants were excluded due to that 
they did not complete the questionnaire survey 
or were not able to provide blood samples
6,663 participants provided all information required
4,313 were eligible and enrolled in COACS
Follow up each year prospectively
2350 subjects were excluded because they had 
at least one history or current chronic diseases 
Clinical 
anthropometrics 





(Cardiovascular Events & 
Cerebrovascular Events) 
Secondary outcomes 
(T2D, COPD, and other 
chronic diseases)
Cardiovascular events & cerebrovascular events 
Fig. 1 Flowchart of the China suboptimal health cohort study (COACS). T2D type 2 diabetes, COPD chronic obstructive pulmonary disease
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Table 3 Baseline demographic characteristics of the COACS population stratified by gender
Characteristics Total (n = 4313) Women (n = 2319) Men (n = 1994) P value
Age (years)* 36.9 ± 10.5 37.5 ± 10.4 36.2 ± 10.6 <0.001#
Nationality
 Han 4176 (96.8 %) 2249 (97.0 %) 1927 (96.6 %) 0.524
 Others 137 (3.2 %) 70 (3.0 %) 67 (3.4 %)
Socioeconomic statusa
 ≤¥3000 1393 (32.8 %) 820 (35.9 %) 573 (35.9 %) <0.001#
 ¥3001–5000 2509 (59.1 %) 1316 (57.5 %) 1193 (57.5 %)
 >¥5000 343 (8.1 %) 151 (6.6 %) 192 (6.6 %)
Marital status
 Married with spouse 3778 (87.6 %) 2087 (90.0 %) 1416 (84.8 %) <0.001#
 Widowed, separated, or divorced 69 (1.6 %) 47 (2.0 %) 18 (1.1 %)
 Never married 466 (10.8 %) 185 (8.0 %) 277 (14.1 %)
Highest education completed
 Illiteracy or compulsory education 431 (10.0 %) 255 (11.0 %) 176 (8.8 %) <0.001#
 High school 823 (19.1 %) 510 (22.0 %) 313 (15.7 %)
 College school or higher 3059 (70.9 %) 1554 (67.0 %) 1505 (75.5 %)
Smoking history
 Never 3247 (75.3 %) 2291 (98.8 %) 956 (47.9 %) <0.001#
 Current 976 (22.6 %) 28 (1.2 %) 948 (47.5 %)
 Former 90 (2.1 %) 0 (0.0 %) 90 (4.5 %)
Drinking history
 Never 3024 (70.2 %) 2203 (95.1 %) 821 (41.2 %) <0.001#
 Moderate 762 (17.7 %) 60 (2.6 %) 702 (35.2 %)
 Heavy 524 (12.2 %) 54 (2.3 %) 470 (23.6 %)
Body mass index (kg/m2)b
 <18.5 124 (3.1 %) 101 (4.6 %) 23 (1.3 %) <0.001#
 18.5–23.9 2284 (57.1 %) 1484 (67.9 %) 800 (44.1 %)
 24.0–27.9 1244 (31.1 %) 485 (22.2 %) 759 (41.8 %)
 >28.0 349 (8.7 %) 115 (5.3 %) 234 (12.9 %)
Physical activity
 Inactive 1430 (34.1 %) 848 (37.5 %) 582 (30.1 %) <0.001#
 Moderately 655 (15.6 %) 383 (16.9 %) 272 (14.0 %)
 Very active 2114 (50.3 %) 1032 (45.6 %) 1082 (55.9 %)
Salt intake
 Low 891 (20.7 %) 5794 (25.0 %) 312 (15.6 %) <0.001#
 Medium 2268 (52.6 %) 1243 (53.6 %) 1025 (51.4 %)
 High 1154 (26.8 %) 497 (21.4 %) 657 (32.9 %)
Blood Pressure (mmHg)
 Systolic blood pressure* 116.9 ± 10.8 114.1 ± 10.9 120.1 ± 9.7 <0.001#
 Diastolic blood pressure* 74.5 ± 8.2 72.1 ± 8.2 77.2 ± 7.3 <0.001#
Fasting blood glucose (mmol/L)* 4.93 ± 0.45 4.88 ± 0.43 4.99 ± 0.46 <0.001#
Total cholesterol (mmol/L)* 4.26 ± 0.82 4.22 ± 0.82 4.31 ± 0.82 <0.001#
Triglycerides (mmol/L)* 1.32 ± 1.02 1.09 ± 0.66 1.59 ± 1.26 <0.001#
Suboptimal health status
 SHS (SHSQ score ≥35) 389 (9.0 %) 246 (10.6 %) 143 (7.2 %) <0.001#
 Ideal health (SHSQ score < 35) 3924 (91.0 %) 2073 (89.4 %) 1851 (92.8 %)
Continuous variables were represented as mean ± standard deviation, or median ± interquartile range, while discrete variables were represented as number 
(proportion)
a 80 subjects provided missing data in variable of ‘Socioeconomic status’
b 282 subjects provided missing data in variable of ‘Body Mass Index’
* Mean ± standard deviation
#  P < 0.05
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Table 4 Factors distribution in participant with or without Suboptimal Health Status
Total, n = 4313 (n, %) SHS, n = 389 (n, %) Ideal health, n = 3924 (n, %) P value
Gender
 Male 1994 (46.2 %) 143 (36.8 %) 1851 (47.2 %) <0.001#
 Female 2319 (53.8 %) 246 (63.2 %) 2073 (52.8 %)
Age (years)* 36.9 ± 10.5 36.4 ± 9.1 37.0 ± 10.7 0.287
Nationality
 Han 4176 (96.8 %) 375 (96.5 %) 3801 (96.9 %) 0.352
 Others 137 (3.2 %) 14 (3.6 %) 123 (3.1 %)
Socioeconomic statusa
 <¥3000 1393 (32.8 %) 148 (38.8 %) 1245 (32.2 %) 0.008#
 ¥3000–5000 2509 (59.1 %) 208 (54.6 %) 2301 (59.5 %)
 >¥5000 343 (8.1 %) 25 (6.6 %) 318 (8.2 %)
Marital status
 Married with spouse 3778 (87.6 %) 349 (89.7 %) 3429 (87.4 %) <0.001#
 Widowed, separated, or divorced 69 (1.6 %) 16 (4.1 %) 53 (1.4 %)
 Never married 466 (10.8 %) 24 (6.2 %) 442 (11.3 %)
Highest education completed
 Illiteracy or compulsory education 431 (10.0 %) 28 (7.2 %) 403 (10.3 %) 0.032#
 High school 823 (19.1 %) 68 (17.5 %) 755 (19.2 %)
 College school or higher 3059 (70.9 %) 293 (75.3 %) 2766 (70.5 %)
Smoking history
 Never 3247 (75.3 %) 296 (76.1 %) 2951 (75.2 %) 0.926
 Current 976 (22.6 %) 85 (21.9 %) 891 (22.7 %)
 Former 90 (2.1 %) 8 (2.1 %) 82 (2.1 %)
Drinking history
 Never 3024 (70.2 %) 264 (67.9 %) 2760 (70.4 %) 0.485
 Moderate 762 (17.7 %) 71 (18.3 %) 691 (17.6 %)
 Heavy 524 (12.2 %) 54 (13.9 %) 470 (12.0 %)
Body mass index (kg/m2)b
 <18.5 124 (3.1 %) 22 (5.9 %) 102 (2.8 %) 0.163
 18.5–23.9 2284 (57.1 %) 210 (56.8 %) 2074 (57.1 %)
 24.0–27.9 1244 (31.1 %) 102 (27.6 %) 1142 (31.5 %)
 >28.0 349 (8.7 %) 36 (9.7 %) 313 (8.6 %)
Physical activity
 Inactive 1430 (34.1 %) 166 (44.0 %) 1264 (33.1 %) 0.001#
 Moderately 655 (15.6 %) 64 (17.0 %) 591 (15.5 %)
 Very active 2114 (50.3 %) 147 (39.0 %) 1967 (51.5 %)
Salt intakes
 Low 891 (20.7 %) 79 (20.3 %) 812 (20.7 %) 0.024#
 Medium 2268 (52.6 %) 179 (46.0 %) 2089 (53.2 %)
 High 1154 (26.8 %) 131 (33.7 %) 1023 (26.1 %)
Blood pressure (mmHg)
 Systolic blood pressure 116.9 ± 10.8 114.4 ± 11.1 117.1 ± 10.7 <0.001#
 Diastolic blood pressure 74.5 ± 8.2 73.1 ± 8.3 74.6 ± 8.2 0.001#
Fasting blood glucose (mmol/L)* 4.93 ± 0.45 4.90 ± 0.46 4.94 ± 0.45 0.161
Total cholesterol (mmol/L)* 4.26 ± 0.82 4.22 ± 0.78 4.27 ± 0.82 0.271
Triglycerides (mmol/L)* 1.32 ± 1.01 1.21 ± 0.74 1.33 ± 1.04 0.005#
a 80 subjects provided missing data in variable of ‘Socioeconomic status’
b 282 subjects provided missing data in variable of ‘Body Mass Index’
* Mean ± standard deviation
#  P < 0.05
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incidence of chronic disease. If so, an unprecedented 
opportunity would then exist for the early detection or 
intervention of chronic disease.
Repeated measurement of biomarkers promote precise 
predication of disease progression
Continuous collection of multiple biomarkers, 
together with banking of biological samples (serum, 
plasma, DNA and RNA) will facilitate future investi-
gations of both known and potential new factors that 
put health at risk. The collection will be an important 
resource for future genetic studies. This is especially 
so considering the value of well-characterized popu-
lations for collaborative genetic disease mapping. The 
collection will also allow future genetic and functional 
studies to examine pathological pathways in disease 
processes at the genome, transcriptome, proteome, 
metabolome and glycome levels. The combination of 
objective biomarkers at Omics levels, together with 
subjective health measures such as the SHSQ-25, will 
produce optimal and precise prevention and predic-
tion of disease progression at an individual’s subopti-
mal health stage.
Conclusion
In summary, 4313 participants (53.8  % women) aged 
18–65  years were included in the cohort, and the 
prevalence of SHS in all participants was 9.0  % using 
a threshold of SHS score of 35. Based on the baseline 
cross-sectional study, the pilot study showed that risk 
factors for chronic diseases (such as socio-economic 
status, marital status, highest education completed, 
physical activity, salt intake, the blood pressure and tri-
glycerides)differed significantly between subjects of 
SHS (SHS score  ≥35) and those of ideal health (SHS 
score  <35). The COACS study is a community-based, 
real-life environment, prospective study to investigate 
whether SHS, along with life-style and other socio-eco-
nomic factors, contributes to the incidence of chronic 
disease in Chinese adults. Furthermore, the COACS 
study affords the opportunity to longitudinally analyze 
the genetic, lifestyle and environmental factors that may 
determine onset and etiology of targeted chronic dis-
ease. The study together with the designed prospective 
cohort provides a chance to characterize and evaluate 
the effect of SHS systemically, and it thus generates an 
unprecedented opportunity for the early detection and 
prevention of chronic disease.
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